Carcell Biopharma
科镁信Carcell Biopharma
Carcell Biopharma
Biotech/Healthcare
Kemeixin is a biopharmaceutical company incubated by EVX Ventures. Through a diversified platform model, it develops technologies designed to advance next-generation cell and gene therapies.
Latest round: Pre Series A (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.